PSMA and FDG PET/CT Findings in Patient With Dedifferentiated Liposarcoma and Prostate Cancer Metastases

被引:0
|
作者
Liao, Xuhe [1 ]
Sun, Hongwei [1 ]
Chen, Xueqi [1 ]
Fan, Yan [1 ]
Zhang, Jianhua [1 ]
机构
[1] Peking Univ First Hosp, Dept Nucl Med, Beijing 100034, Peoples R China
关键词
F-18-PSMA; liposarcoma; PET/CT; F-18-FDG;
D O I
10.1097/RLU.0000000000005252
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Dedifferentiated liposarcoma is an extremely rare and highly malignant tumor. We demonstrated a case of a 75-year-old man with significantly PSMA-avid and mildly FDG uptake-dedifferentiated liposarcoma in the retroperitoneal area. The double-tracer (PSMA and FDG) PET scans could further contribute to differential diagnosis and the following treatment strategy for patients who were suspected with prostate cancer metastases and other malignant tumors simultaneously.
引用
收藏
页码:652 / 654
页数:3
相关论文
共 50 条
  • [41] The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
    Kase, Adam M.
    Tan, Winston
    Copland, John A., III
    Cai, Hancheng
    Parent, Ephraim E.
    Madan, Ravi A.
    CANCERS, 2022, 14 (06)
  • [42] 68Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer
    Jonathan Damjanovic
    Jan-Carlo Janssen
    Christian Furth
    Gerd Diederichs
    Thula Walter
    Holger Amthauer
    Marcus R. Makowski
    Cancer Imaging, 18
  • [43] Dual time psma pet/ct with diuretics and contrast to detect prostate cancer pelvic metastases: is there a benefit?
    Tognoli, T.
    Camacho, M. R. F.
    Santos, A. O.
    Lima, M. C. L.
    Amorim, B. J.
    Ferreira, U.
    Etchebehere, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S534 - S534
  • [44] Artificial intelligence for the detection of primary tumour, recurrence and metastases in PSMA PET-CT in prostate cancer
    Tragardh, E.
    Enqvist, O.
    Ulen, J.
    Jogi, J.
    Edenbrandt, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S270 - S270
  • [45] 68Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer
    Damjanovic, Jonathan
    Janssen, Jan-Carlo
    Furth, Christian
    Diederichs, Gerd
    Walter, Thula
    Amthauer, Holger
    Makowski, Marcus R.
    CANCER IMAGING, 2018, 18
  • [46] Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT
    Stanzel, Susanne
    Weitzer, Friedrich
    Janek, Elmar
    Plhak, Elisabeth
    Aigner, Reingard M.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1064 - 1065
  • [47] Case report: Systemic tuberculosis with prostate involvement mimicking prostate cancer with multiple metastases on 18F-FDG and 18F-PSMA PET/CT
    Sun, Xinyao
    Qiu, Yongkang
    Song, Lele
    Kang, Lei
    FRONTIERS IN MEDICINE, 2024, 11
  • [48] Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases
    Kara, P. Ozcan
    Kara, T.
    Gedik, G. Kara
    Sari, O.
    Sahin, O.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (02): : 94 - 96
  • [49] Widespread Metastases in Small Cell Carcinoma of the Prostate on FDG PET/CT
    Yilmaz, Mustafa
    Celen, Zeki
    Sevinc, Alper
    Karakok, Metin
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (09) : 598 - 600
  • [50] Prolapsed endometrial cancer: FDG PET/CT findings
    Kaneta, T
    Hakamatsuka, T
    Yamada, T
    Sato, A
    Higano, S
    Fukuda, H
    Takahashi, S
    Yamada, S
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (03) : 180 - 180